XML 21 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Financial Condition - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Cash and cash equivalents:    
Cash and due from banks $ 2,142,294 $ 844,532
Money market investments 11,908 6,775
Total cash and cash equivalents 2,154,202 851,307
Restricted cash 1,375 1,450
Investments:    
Trading securities, at fair value, with amortized cost of $432 (December 31, 2019 - $182) 22 37
Investment securities available-for-sale, at fair value, with amortized cost of $432,176 (December 31, 2019, amortized cost $1,074,475); no allowance for credit losses 446,438 1,074,169
Federal Home Loan Bank (FHLB) stock, at cost 8,278 13,048
Other investments 3,962 560
Total investments 458,700 1,087,814
Loans:    
Loans held-for-sale, at lower of cost or fair value 43,935 19,591
Loans held for investment, net of allowance for credit losses of $204,809 (December 31, 2019 - $116,539) 6,457,324 6,622,256
Total loans 6,501,259 6,641,847
Other assets:    
Foreclosed real estate 11,596 29,909
Accrued interest receivable 65,547 37,120
Deferred tax asset, net 162,478 176,740
Premises and equipment, net 83,786 81,105
Customers' liability on acceptances 33,349 21,599
Servicing assets 47,295 50,779
Goodwill 86,069 86,069
Other intangible assets 45,896 56,965
Operating lease right-of-use assets 31,383 39,112
Other assets 143,076 135,845
Total assets 9,826,011 9,297,661
Deposits:    
Demand deposits 4,613,309 3,579,115
Savings accounts 1,944,415 1,836,480
Time deposits 1,857,916 2,283,015
Total deposits 8,415,640 7,698,610
Borrowings:    
Securities sold under agreements to repurchase 0 190,274
Advances from FHLB 65,561 78,009
Subordinated capital notes 36,083 36,083
Other borrowings 707 1,195
Total borrowings 102,351 305,561
Other liabilities:    
Derivative liabilities 1,712 913
Acceptances executed and outstanding 33,349 21,599
Operating lease liabilities 32,566 39,840
Accrued expenses and other liabilities 154,418 185,660
Total liabilities 8,740,036 8,252,183
Commitments and contingencies (See Note 26)
Stockholders' equity:    
Preferred stock; 10,000,000 shares authorized; 1,340,000 shares of Series A, 1,380,000 shares of Series B, and 960,000 shares of Series D issued and outstanding (December 31, 2019 - 1,340,000 shares; 1,380,000 shares; and 960,000 shares) $25 liquidation value 92,000 92,000
Common stock, $1 par value; 100,000,000 shares authorized; 59,885,234 shares issued: 51,387,071 shares outstanding (December 31, 2019 - $59,885,234; 51,398,956) 59,885 59,885
Additional paid-in capital 622,652 621,515
Legal surplus 103,269 95,779
Retained earnings 300,096 279,646
Treasury stock, at cost, 8,498,163 shares (December 31, 2019 - 8,486,278 shares) (102,949) (102,339)
Accumulated other comprehensive income (loss), net of tax of $-1,529 (December 31, 2019 - $206) 11,022 (1,008)
Total stockholders' equity 1,085,975 1,045,478
Total liabilities and stockholders' equity $ 9,826,011 $ 9,297,661